| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 7390570 | Value in Health Regional Issues | 2014 | 5 Pages |
Abstract
EGFR testing should be considered before administering EGFR tyrosine-kinase inhibitor such as gefitinib as first-line treatment in patients with non-small cell lung cancer in Thailand where the incidence of EGFR mutation is high.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Unchalee PhD, Narawadee PhD, Narumon MPH, Sumitra MD,